Re-exposure to immunotherapy in metastatic colon cancer: A case report.

Tonje Riise HamreJulie Kristine StougaardBirgitte Mayland HavelundLars Henrik Jensen Torben Frøstrup Hansen

Published in: Clinical case reports (2021)

Re-exposure to immunotherapy in metastatic colorectal cancer may be indicated in selected patients that previously benefitted from immunotherapy with tolerable irAEs.

Keyphrases

metastatic colorectal cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
squamous cell carcinoma
small cell lung cancer
peritoneal dialysis